Stay updated on Upadacitinib in RA: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in RA: Safety & Efficacy Clinical Trial page.

Latest updates to the Upadacitinib in RA: Safety & Efficacy Clinical Trial page
- Check2 days agoChange DetectedThe footer now displays site revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check9 days agoChange DetectedAn NIH-wide announcement banner directs visitors to transition updates and notes that NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check16 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2; the study record page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedThe site revision label changed from v3.7.0 to v3.7.1. The study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page now displays a 403 Forbidden error screen for the study record, replacing the expected content with a minimal header, navigation, and a Home button.SummaryDifference19%

- Check50 days agoChange DetectedRelated topics were added to the page, including Rheumatoid arthritis and a MedlinePlus Genetics entry. This expansion adds contextual disease terminology and links to genetics information on the study details page.SummaryDifference0.1%

Stay in the know with updates to Upadacitinib in RA: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in RA: Safety & Efficacy Clinical Trial page.